SAB Biotherapeutics Inc. (SABS) - 13D/13G Filings

Real time Form 13D and 13G transaction reports:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
  • Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Goto Prev, 0, 1
Reported
DateTime
Transaction
Date
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportView
2022-02-14
06:09 am
Sale
2021-12-3113GSAB BIOTHERAPEUTICS INC
SABS
Radcliffe Capital Management L.P.62,756
1.440%
-66,933decrease
(-51.61%)
Filing
History
2022-02-11
3:39 pm
Sale
2021-12-3113GSAB BIOTHERAPEUTICS INC
SABS
BASSO CAPITAL MANAGEMENT L.P.0
0.000%
-75,779decrease
(Position Closed)
Filing
History
2021-11-01
7:38 pm
Purchase
2021-10-2213DSAB BIOTHERAPEUTICS INC
SABS
Big Cypress Holdings LLC304,933
7.000%
304,933increase
(New Position)
Filing
History
2021-11-01
4:57 pm
Purchase
2021-10-2213DSAB BIOTHERAPEUTICS INC
SABS
HAMILTON CHRISTINE E1,068,598
24.580%
1,068,598increase
(New Position)
Filing
History
2021-11-01
4:55 pm
Purchase
2021-10-2213DSAB BIOTHERAPEUTICS INC
SABS
Sullivan Eddie Joe570,511
13.120%
570,511increase
(New Position)
Filing
History
2021-10-19
09:51 am
Purchase
2021-10-1313GBIG CYPRESS ACQUISITION CORP C
BCYP
Radcliffe Capital Management L.P.1,296,891
8.770%
1,296,891increase
(New Position)
Filing
History
Goto Prev, 0, 1